45% of Young Investors Own Crypto as Housing Dreams Fade: Survey
Younger investors are allocating 25% of portfolios to non-traditional assets including crypto, triple the 8% rate among older generations, as rising housin...
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Coinbase, Robinhood and Circle are expanding into stablecoins, payments and prediction markets, but their latest earnings show how hard it is to escape cry...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Younger investors are allocating 25% of portfolios to non-traditional assets including crypto, triple the 8% rate among older generations, as rising housin...
The token's short-term price action is sluggish, with trading volume spiking during sell-offs. Technical charts show support at $830 and resistance at $845...
Micron, Lululemon and Trump Media rise premarket; CarMax falls
Nasdaq Edges Lower as AI Chipmakers Face Selling Pressure
Histrorically, after years of 100% returns or better, the following twelve months are generally poor for silver.
India is exploring asset tokenization as a way to open high-value investments such as real estate, infrastructure, and carbon credits to middle-class citiz...
New rumors of stalled data-center funding have sent Oracle's stock lower, but some experts argue the negative narrative has gotten too harsh.
Stock indexes fall while gold and silver rise with oil
More than 46,000 claimants could potentially receive a payout from a court-approved settlement involving the FTX-tied Silvergate Bank, which shuttered in 2...
XRP's price action now faces resistance at the former support levels, with $1.90 as the immediate line of defense.
Sui (SUI) was also an underperformer, declining 2.4% from Tuesday.
Moleculin Biotech stock falls after pediatric brain tumor trial results